Clinical Trial Update: A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update reports the results of a pivotal open-label Phase 2 study of Brentuximab Vedotin in Hodgkin lymphoma, sponsored by Seagen Inc. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: Seagen Inc. | Conditions: Disease, Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2011-10-26